HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiao Hu Selected Research

endostar protein

1/2021Five-year survival rate analysis: the combination of fortnightly-administration of endostar and concurrent chemoradiotherapy versus concurrent chemoradiotherapy in the treatment of inoperable locally advanced non-small cell lung cancer.
5/2016Prognostic performance of inflammation-based prognostic indices in locally advanced non-small-lung cancer treated with endostar and concurrent chemoradiotherapy.
2/2015Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer.
1/2012Recombinant human endostatin normalizes tumor vasculature and enhances radiation response in xenografted human nasopharyngeal carcinoma models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiao Hu Research Topics

Disease

93Neoplasms (Cancer)
04/2024 - 09/2006
35Inflammation (Inflammations)
02/2024 - 08/2011
19Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2024 - 10/2008
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 01/2013
12Hypoxia (Hypoxemia)
02/2023 - 01/2012
11Infections
05/2024 - 02/2020
11Alzheimer Disease (Alzheimer's Disease)
01/2024 - 01/2013
10Hypertension (High Blood Pressure)
03/2024 - 08/2005
10Neoplasm Metastasis (Metastasis)
02/2024 - 03/2011
9Fibrosis (Cirrhosis)
05/2024 - 05/2013
9Neuroinflammatory Diseases
03/2024 - 05/2017
8Hepatocellular Carcinoma (Hepatoma)
11/2023 - 01/2016
8Carcinoma (Carcinomatosis)
04/2023 - 05/2009
8Carcinogenesis
02/2023 - 01/2016
8Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 11/2017
8Breast Neoplasms (Breast Cancer)
04/2022 - 01/2018
7Brain Injuries (Brain Injury)
02/2024 - 02/2006
7Stroke (Strokes)
02/2024 - 01/2020
7Lung Neoplasms (Lung Cancer)
11/2023 - 12/2012
7Wounds and Injuries (Trauma)
03/2023 - 01/2014
7COVID-19
05/2021 - 09/2020
6Atherosclerosis
02/2024 - 02/2013
6Multiple Sclerosis
01/2017 - 10/2010
5Ischemic Stroke
03/2024 - 11/2018
5Heart Failure
02/2024 - 08/2005
5Pneumonia (Pneumonitis)
01/2024 - 02/2020
5Obesity
05/2023 - 05/2015
5Cicatrix (Scar)
04/2023 - 05/2013
5Prostatic Neoplasms (Prostate Cancer)
04/2023 - 03/2011
5Hemorrhage
01/2023 - 01/2014
5Autoimmune Diseases (Autoimmune Disease)
01/2023 - 10/2010
5Liver Cirrhosis (Hepatic Cirrhosis)
09/2021 - 12/2017
5Cleft Palate (Palate, Cleft)
05/2016 - 05/2011
4Cerebral Hemorrhage
02/2024 - 01/2021
4Body Weight (Weight, Body)
01/2024 - 12/2012
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2024 - 01/2017
4Brain Neoplasms (Brain Tumor)
01/2024 - 01/2022
4Type 2 Diabetes Mellitus (MODY)
01/2024 - 06/2012
4Ischemia
11/2023 - 01/2020
4Cholangiocarcinoma
03/2023 - 01/2011
4Virus Diseases (Viral Diseases)
01/2023 - 10/2020
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 01/2017
4Fatty Liver
11/2020 - 01/2017
4Pituitary Neoplasms (Pituitary Adenoma)
08/2019 - 01/2015
3Major Depressive Disorder (Major Depressive Disorders)
05/2024 - 09/2022
3Anemia
03/2024 - 01/2019
3Chronic Renal Insufficiency
03/2024 - 01/2020
3Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
03/2024 - 01/2021
3Cognitive Dysfunction
01/2024 - 04/2021
3Brain Ischemia (Cerebral Ischemia)
11/2023 - 08/2013
3Neurodegenerative Diseases (Neurodegenerative Disease)
10/2023 - 01/2006
3Health Personnel Alert Fatigue
07/2023 - 01/2018

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
02/2024 - 05/2002
23Biomarkers (Surrogate Marker)IBA
05/2024 - 03/2012
13CytokinesIBA
05/2024 - 12/2015
9MicroRNAs (MicroRNA)IBA
08/2023 - 01/2015
8RNA (Ribonucleic Acid)IBA
01/2023 - 10/2020
8Messenger RNA (mRNA)IBA
01/2021 - 03/2011
7CholesterolIBA
10/2023 - 11/2017
7LigandsIBA
01/2023 - 08/2011
7ParaquatIBA
01/2021 - 01/2017
6Cisplatin (Platino)FDA LinkGeneric
04/2024 - 07/2010
6AlbuminsIBA
03/2024 - 08/2010
6Therapeutic UsesIBA
12/2023 - 08/2019
6Immune Checkpoint InhibitorsIBA
11/2023 - 12/2019
6Glucose (Dextrose)FDA LinkGeneric
01/2023 - 01/2012
6NF-kappa B (NF-kB)IBA
01/2021 - 01/2011
5CollagenIBA
05/2024 - 05/2013
5AntioxidantsIBA
12/2023 - 11/2017
5Polyvinyl Chloride (PVC)IBA
07/2023 - 01/2014
5Antiviral Agents (Antivirals)IBA
01/2023 - 11/2020
5Peptides (Polypeptides)IBA
04/2022 - 12/2017
5Long Noncoding RNAIBA
01/2021 - 09/2017
4Etoposide (VP 16)FDA LinkGeneric
04/2024 - 07/2010
4Hemoglobins (Hemoglobin)IBA
03/2024 - 11/2022
4Streptozocin (Streptozotocin)FDA Link
01/2024 - 01/2018
4Neuroprotective AgentsIBA
11/2023 - 07/2013
4MicronutrientsIBA
05/2023 - 12/2013
4AntigensIBA
03/2023 - 01/2020
4Fatty Acids (Saturated Fatty Acids)IBA
02/2023 - 11/2020
4Trans Fatty AcidsIBA
02/2023 - 01/2017
4AcidsIBA
01/2023 - 12/2017
4EnzymesIBA
12/2021 - 01/2015
4endostar proteinIBA
01/2021 - 01/2012
4SolutionsIBA
01/2021 - 10/2010
4InterferonsIBA
01/2021 - 09/2011
4Oxygen (Dioxygen)IBA
03/2018 - 01/2012
4peginterferon beta-1aIBA
01/2017 - 02/2015
3InflammasomesIBA
03/2024 - 01/2021
3p38 Mitogen-Activated Protein KinasesIBA
12/2023 - 05/2015
3HydrogelsIBA
12/2023 - 10/2021
3LipidsIBA
11/2023 - 01/2021

Therapy/Procedure

47Therapeutics
02/2024 - 09/2006
26Radiotherapy
04/2024 - 10/2008
15Drug Therapy (Chemotherapy)
04/2024 - 10/2008
10Chemoradiotherapy
04/2024 - 02/2015
8Immunotherapy
03/2024 - 01/2016
5Cranial Irradiation
04/2024 - 07/2013
4Ligation
05/2024 - 01/2020
4Aftercare (After-Treatment)
03/2024 - 05/2018